llms.txt

Exin Therapeutics Brand Identity

A complete profile of Exin Therapeutics's visual system — colors, typography, components, and personality.

Quick Facts

Field	Value
Primary	#226E93
Accent	#1E6C93
Body Font	Lato
Heading Font	Lato

Color Palette

primary: #226E93
accent: #1E6C93
background: #FFFFFF
textPrimary: #212121
link: #1E6C93

Typography

primary: Lato — https://fonts.google.com/specimen/Lato
heading: Lato — https://fonts.google.com/specimen/Lato

Visual Assets

Logo:
Favicon:
Social card (og:image):

UI Components

input: background=transparent, textColor=#000000, borderColor=null, borderRadius=0px, shadow=none

Brand Personality

Tone: professional · Energy: medium · Audience: healthcare professionals and patients

Exin Therapeutics Brand in the Wild

Real-world brand assets — ads, campaigns, marketing materials.

How Exin Therapeutics hit $550K revenue with a 5 person team in...

Source: getlatka.com
Exin Therapeutics (YC W25) is developing genetic therapies targeting neural activity for people suffering from neurological and neuropsychiatric disorders - tackling conditions like epilepsy… | Y Combinator | 11 comments

Source: linkedin.com
Exin Therapeutics (YC W25) is developing genetic therapies targeting neural activity for people suffering from neurological and neuropsychiatric disorders - tackling conditions like epilepsy… | Y Combinator | 11 comments

Source: linkedin.com
Exin Therapeutics Launches: Genetic Therapies Targeting Neural Activity | Fondo

Source: fondo.com
First Philippine neurotherapeutics laboratory gets green lane certificate - Manila Standard

Source: manilastandard.net

Working with these fonts

(Instructions for font use are omitted for brevity.)

Machine-Readable Profile

{
 "colorScheme": "light",
 "fonts": [
 {
 "family": "Lato",
 "role": "body"
 },
 {
 "family": "Roboto",
 "role": "unknown"
 },
 {
 "family": "Arial",
 "role": "unknown"
 },
 {
 "family": "Google Sans",
 "role": "unknown"
 }
 ],
 "colors": {
 "primary": "#226E93",
 "accent": "#1E6C93",
 "background": "#FFFFFF",
 "textPrimary": "#212121",
 "link": "#1E6C93"
 },
 "typography": {
 "fontFamilies": {
 "primary": "Lato",
 "heading": "Lato"
 },
 "fontStacks": {
 "heading": [
 "Lato",
 "sans-serif"
 ],
 "body": [
 "sans-serif"
 ],
 "paragraph": [
 "Lato",
 "sans-serif"
 ]
 },
 "fontSizes": {
 "h1": "45.3333px",
 "h2": "45.3333px",
 "body": "14.6667px"
 }
 },
 "spacing": {
 "baseUnit": 4,
 "borderRadius": "0px"
 },
 "components": {
 "input": {
 "background": "transparent",
 "textColor": "#000000",
 "borderColor": null,
 "borderRadius": "0px",
 "borderRadiusCorners": {
 "topLeft": "0px",
 "topRight": "0px",
 "bottomRight": "0px",
 "bottomLeft": "0px"
 },
 "shadow": "none"
 }
 },
 "images": {
 "logo": "https://lh3.googleusercontent.com/sitesv/AA5AbUDzUlH2YqEmcWGcXBZYzXuiEpBkeqhvjkFFPgZ06cphZut8W6LGLSiqAqgMOgokXWwzYvmjQBHjnjTROLAun0kmfDwqR6ifbYbf98A_G56PTrOZ0xiozB65GEngsmvGsaXvNiCsQG-ZUFU4U3SWum2jMdFqx0tsVhMA6ntTafV3FUY0O_YyHcm1=w16383",
 "favicon": "https://lh3.googleusercontent.com/sitesv/AA5AbUA8z2oZdM8oTSUPUq3yIFc_uBl-ZuNaFiXdhl7SY0xz3UfMgHb3-TmdABQk-PKNcr6te-aC_kPLNivagGKogyWAxgYIR8BusugjYfS-FI9_pcDQ9fAGW8-UIa2cZqZuERdnq0uzT2QcyCOjIze7iTLESP2qIVUqIAPvELf51IJDR1gUkG6WxCtezFVRi5xv7Zf6G11jDaNeSASZDKTpag",
 "ogImage": "https://lh3.googleusercontent.com/sitesv/AA5AbUDzUlH2YqEmcWGcXBZYzXuiEpBkeqhvjkFFPgZ06cphZut8W6LGLSiqAqgMOgokXWwzYvmjQBHjnjTROLAun0kmfDwqR6ifbYbf98A_G56PTrOZ0xiozB65GEngsmvGsaXvNiCsQG-ZUFU4U3SWum2jMdFqx0tsVhMA6ntTafV3FUY0O_YyHcm1=w16383",
 "logoHref": "/science"
 },
 "personality": {
 "tone": "professional",
 "energy": "medium",
 "targetAudience": "healthcare professionals and patients"
 },
 "designSystem": {
 "framework": "custom",
 "componentLibrary": ""
 },
 "confidence": {
 "buttons": 0.9,
 "colors": 0.9,
 "overall": 0.9
 }
}